| Literature DB >> 30901869 |
Dong Xu1, Meng-Jiao Hu2, Yan-Qiu Wang3, Yuan-Lu Cui4.
Abstract
Quercetin is a bioactive compound that is widely used in botanical medicine and traditional Chinese medicine due to its potent antioxidant activity. In recent years, antioxidant activities of quercetin have been studied extensively, including its effects on glutathione (GSH), enzymatic activity, signal transduction pathways, and reactive oxygen species (ROS) caused by environmental and toxicological factors. Chemical studies on quercetin have mainly focused on the antioxidant activity of its metal ion complexes and complex ions. In this review, we highlight the recent advances in the antioxidant activities, chemical research, and medicinal application of quercetin.Entities:
Keywords: antioxidant activity; complex; oxidative stress; polyphenol; quercetin
Mesh:
Substances:
Year: 2019 PMID: 30901869 PMCID: PMC6470739 DOI: 10.3390/molecules24061123
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structure and bibliometric results of quercetin. (a) Chemical structure of quercetin. (b) 3D conformer of quercetin. (c) Co-occurrence map of quercetin. The figure is based on data in the Web of Science (WOS) database ranging from 2000 to 2017, and was drawn by CiteSpace. The diameter of a node represents the number of occurrences of keywords. The larger the diameter, the greater the number of appearances.
Figure 2The antioxidant signaling pathway regulated by quercetin. Environmental factors increase the production of reactive oxygen species (ROS). The mitochondrial electron transport chain (mito ETC) is another robust source of intracellular ROS generation. Quercetin can regulate the enzyme-mediated antioxidant defense system and the non-enzyme-dependent antioxidant defense system. It can also regulate signal pathways such as NRFB, AMPK, and MAPK caused by ROS to promote the antioxidant defense system and maintain oxidative balance. ROS in turn enhance the production of APE1/Ref1 and the activation of several signaling events including p53-mediated apoptotic events, MAPK pathways, the NF-E2-related factor (NRF2)-mediated activation of genes containing antioxidant response element (ARE), and NF-κB [22,23,24,25,26].
Mechanisms of quercetin for treating damage induced by various factors.
| Inductive Factors | Damage Name | Protection Mechanisms | Result |
|---|---|---|---|
| LPS/d-GalN | Acute liver injury | Inhibits the activation of NF-κB and MAPK signaling pathways and inhibits the expression of apoptosis-related proteins induced by LPS/d-GalN | Decreases the production of LPS/d-GalN induced by oxidation markers [ |
| Toosendanin | Liver toxicity | Induces Nrf2/GCL/GSH antioxidant signal transduction pathways | Increases Nrf2-mediated GCLC/GCLM expression, thereby increasing GSH content in cells [ |
| Alcohol | Liver damage | Regulates phosphoinositide 3-kinase/Akt/NF-κB and STAT3 pathways | Enhances the body’s antioxidant, anti-inflammatory, and anti-apoptotic effects [ |
| A variety of liver toxins | Liver toxicity | Induces p62 expression and inhibits the binding of Keap1 and Nrf2 | Increases the transcription expression of Nrf2-targeted antioxidant genes [ |
| Doxorubicin | Heart toxicity | Upregulates Bmi-1 expression to reduce oxidative stress | Reduces DNA damage at ROS levels and maintains cardiomyocyte viability [ |
| CCl4 | Liver damage | Improves antioxidant activity and regulates TLR2/TLR4 and MAPK/NF-κB signaling pathways | Inhibits ROS production in the liver and attenuates CCl4-induced oxidative damage [ |
| Lead | Liver damage | Reduces oxidative stress in liver, inhibits JNK phosphorylation, and increases PI3K and Akt levels | Effectively inhibits lead-induced endoplasmic reticulum stress [ |
| Cadmium | Cerebral cholinergic dysfunction | Reduces the production of ROS and protects the integrity of the line by regulating the protein involved in apoptosis and MAPK signal conduction | Regulates molecular targets involved in the signal conduction of brain cholinergic energy and reduces the neurotoxicity of cadmium [ |
| Malignant cell transformation | Protects BEAS-2B cells from Cr (VI) induction by targeting miR-21-PDCD4 signaling | Reduces ROS production induced by Cr (VI) exposure in BEAS-2B cells [ | |
| Cognitive impairment and neuron degeneration or loss | Improves the Nrf2-ARE signaling pathway | Decreases free radicals, increases antioxidant enzyme activity, improves overall antioxidant capacity, and slows down aging by improving Nrf2 [ | |
| Receptor activator for NF-κB ligand | Osteoblast differentiation | Regulates the transcription activities of NF-κB and AP-1 | Inhibits the NF-κB and AP-1 mechanism activation [ |
Figure 3Basic principle of antioxidant activity of quercetin [78,79,80,81].